{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T02:03:40Z","timestamp":1649037820519},"reference-count":93,"publisher":"Informa Healthcare","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Emerging Drugs"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1517\/14728214.12.1.127","type":"journal-article","created":{"date-parts":[[2007,3,14]],"date-time":"2007-03-14T11:44:10Z","timestamp":1173872650000},"page":"127-137","source":"Crossref","is-referenced-by-count":9,"title":["Emerging drugs for mesothelioma"],"prefix":"10.1517","volume":"12","author":[{"given":"Giorgio Vittorio","family":"Scagliotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Selvaggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2007,3,14]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.30237"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1093\/annhyg\/44.8.565"},{"key":"CIT0003","unstructured":"Mesothelioma occupation statistics: male and female deaths aged 16 \u2013 74 in Great Britain, 1980 \u2013 2000 (excluding 1981). Health and Safety Executive Publications, Merseyside, England, UK (2003)."},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.30227"},{"key":"CIT0005","first-page":"1781","volume":"9","author":"CARBONE","year":"1994","journal-title":"Oncogene"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.26.2.f229"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690105"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009093"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026300619747"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.4.250"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.10047"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050152"},{"key":"CIT0013","unstructured":"SEGAL A, WHITAKER D, HENDERSON D, SHILKIN K: Pathology of mesothelioma. In:Mesothelioma.Robinson BW, Chahinian AP (Eds), Martin Dunitz, London, UK (2002):143-184."},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1148\/rg.241035058"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.3.723"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.9.731"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2004.04.025"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2005.03.007"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.8999"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.4.1122"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.01.034"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200303000-00004"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1007\/BF02306613"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199002000-00002"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.3.754"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1097\/00130404-200311000-00008"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(94)91066-9"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2005.03.015"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2003.n.023"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1097\/01243894-200607000-00017"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1007\/BF00175403"},{"key":"CIT0032","first-page":"1431","volume":"69","author":"SORENSEN","year":"1985","journal-title":"Cancer Treat. Rep."},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1992.200"},{"key":"CIT0034","first-page":"1436","volume":"12","author":"VOGELZANG","year":"1994","journal-title":"J"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.465"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(02)00180-0"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600673"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011139918558"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2577::AID-CNCR13>3.0.CO;2-S"},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.1999.17.1.25","volume":"17","author":"BYRNE","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"CIT0041","first-page":"342","volume":"86","author":"VAN HAARST","year":"2002","journal-title":"Br"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.1.274"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1016\/S0093-7754(02)70040-7"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.122"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.136"},{"key":"CIT0046","first-page":"5579","volume":"51","author":"JACKMAN","year":"1991","journal-title":"Cancer Res."},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(02)00668-8"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.05.123"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20005.14.589"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1007\/BF00685720"},{"key":"CIT0051","first-page":"1016","volume":"6","author":"TEICHER","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.10.073"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.3190"},{"key":"CIT0054","doi-asserted-by":"crossref","unstructured":"FENNELL D, STEELE J, SHEAFF Met al.: Response of malignant pleural mesothelioma to chemotherapy does not confer a survival advantage.Proceedings of the 11th World Conference on Lung Cancer.Barcelona, Spain (2005):P-397.","DOI":"10.1016\/S0169-5002(05)80890-6"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.2003.009290"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj073"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2003.n.009"},{"key":"CIT0058","doi-asserted-by":"crossref","unstructured":"BOYAR MS, HESDORFFER M, TAUB RN: Phase II trial of oxaliplatin and gemcitabine in patients with malignant pleural or peritoneal mesothelioma.Proceedings of 42nd the ASCO Annual Meeting.Atlanta, GA, USA (2006):17133.","DOI":"10.1200\/jco.2006.24.18_suppl.17133"},{"key":"CIT0059","doi-asserted-by":"crossref","unstructured":"TALBOT D, MARGERY J, DABUIS Get al.: Interim results of the Phase II study of vinflunine (VFL) in malignant pleural mesothelioma (MPM).Proceedings of 41st the ASCO Annual Meeting.Orlando, FL, USA (2005):7171.","DOI":"10.1200\/jco.2005.23.16_suppl.7171"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2005.10.016"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2006.08.012"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040938"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1593\/neo.04271"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1940"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1038\/nm0195-27"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2004.04.025"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199706)182:2<211::AID-PATH834>3.0.CO;2-D"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690650"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10996"},{"key":"CIT0070","doi-asserted-by":"crossref","unstructured":"KINDLER HL, KARRISON T, LU Cet al.: A multicenter, double-blind, placebo-controlled randomized Phase II trial of gemcitabine\/cisplatin (GC) plus bevacizumab (B) or placebo in patients (pts) with malignant mesothelioma (MM).Proceedings of 42nd the ASCO Annual Meeting.Atlanta, GA, USA (2006):7019.","DOI":"10.1200\/jco.2005.23.16_suppl.7019"},{"key":"CIT0071","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1200\/JCO.2000.18.4.708","volume":"18","author":"FINE","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"CIT0072","doi-asserted-by":"crossref","unstructured":"PAVLAKIS N, ABRAHAM R, HARVIE R: Thalidomide alone or in combination with cisplatin\/gemcitabine in malignant pleural mesothelioma (MM): interim results of two parallel non randomised Phase II studies.Proceedings of the 10th World Conference on Lung Cancer.Vancouver, Canada (2003):O-26.","DOI":"10.1016\/S0169-5002(03)91684-9"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2004.10.005"},{"key":"CIT0074","doi-asserted-by":"crossref","unstructured":"JAHAN TM, GU L, WANG Xet al.: Vatalanib (V) for patients with previously untreated advanced malignant mesothelioma (MM): a Phase II study by the Cancer and Leukemia Group B (CALGB 30107).Proceedings of the 42nd ASCO Annual Meeting.Atlanta, GA, USA (2006):7081.","DOI":"10.1016\/S0169-5002(05)80896-7"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1054\/ghir.2001.0256"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.5.1843"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-3192"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.14.167"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.9679"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2006.n.003"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980105)75:1<51::AID-IJC9>3.0.CO;2-0"},{"key":"CIT0082","first-page":"2108","volume":"9","author":"ILLEI","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0313"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.8.636"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0073"},{"key":"CIT0086","doi-asserted-by":"crossref","unstructured":"KOSURI KV, OTTERSON G: The role of methylation leading to capecitabine resistant malignant mesothelioma.Proceedings of 42nd the ASCO Annual Meeting.Atlanta, GA, USA (2006):17105.","DOI":"10.1200\/jco.2006.24.18_suppl.17105"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.071"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.043"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060467"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2181"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-0607-3"},{"key":"CIT0092","first-page":"3080","volume":"9","author":"SINGHAL","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3907"}],"container-title":["Expert Opinion on Emerging Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14728214.12.1.127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T21:18:56Z","timestamp":1587417536000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14728214.12.1.127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2007,3,14]]},"published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1517\/14728214.12.1.127"],"URL":"https:\/\/doi.org\/10.1517\/14728214.12.1.127","relation":{},"ISSN":["1472-8214","1744-7623"],"issn-type":[{"value":"1472-8214","type":"print"},{"value":"1744-7623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}